Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 8, 2024
A Deep Learning-Based Assay for Programmed Death Ligand 1 Immunohistochemistry Scoring in Non-Small Cell Lung Carcinoma: Does it Help Pathologists Score?Hiroaki Ito, Akihiko Yoshizawa, Kazuhiro Terada, et al.
Lung Cancer (Amsterdam, Netherlands)|November 30, 2022
A novel cell-based assay for the high-throughput screening of epithelial-mesenchymal transition inhibitors: Identification of approved and investigational drugs that inhibit epithelial-mesenchymal transitionHiroyuki Ishikawa, Toshi Menju, Toshiya Toyazaki, et al.
Cell Death & Disease|March 11, 2020
MCL1 inhibition is effective against a subset of small-cell lung cancer with high MCL1 and low BCL-XL expressionYuto Yasuda, Hiroaki Ozasa, Young Hak Kim, et al.
Cancer Medicine|October 17, 2015
Association between epithelial-mesenchymal transition and cancer stemness and their effect on the prognosis of lung adenocarcinomaTerumasa Sowa, Toshi Menju, Makoto Sonobe, et al.
Oncology Reports|August 12, 2022
Nrf2/p‑Fyn/ABCB1 axis accompanied by p‑Fyn nuclear accumulation plays pivotal roles in vinorelbine resistance in non‑small cell lung cancerShigeyuki Tamari, Toshi Menju, Toshiya Toyazaki, et al.
Molecular Cancer Therapeutics|December 5, 2023
Combination Therapy with EGFR Tyrosine Kinase Inhibitors and TEAD Inhibitor Increases Tumor Suppression Effects in EGFR Mutation-positive Lung CancerTatsuya Ogimoto, Hiroaki Ozasa, Takahiro Tsuji, et al.
Interactive Cardiovascular and Thoracic Surgery|October 15, 2021
Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors as a first-line treatment for postoperative recurrent and EGFR-mutated non-small-cell lung cancerTetsuji Moriya, Masatsugu Hamaji, Akihiko Yoshizawa, et al.
Cancer Medicine|January 11, 2018
The synergistic role of ATP-dependent drug efflux pump and focal adhesion signaling pathways in vinorelbine resistance in lung cancerTakao Nakanishi, Toshi Menju, Shigeto Nishikawa, et al.
Journal of Thoracic Disease|May 25, 2026
Development of a model to predict high-risk histopathological features in early T-stage lung adenocarcinoma using thin-slice CT and FDG-PET/CT parameters for selecting optimal candidates for sub-lobar resectionSuzune Tsukamoto, Sho Koyasu, Masatsugu Hamaji, et al.
Transplantation|February 17, 2017
Association of Local Intrapulmonary Production of Antibodies Specific to Donor Major Histocompatibility Complex Class I With the Progression of Chronic Rejection of Lung AllograftsEi Miyamoto, Hideki Motoyama, Masaaki Sato, et al.
Pageof 13